Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: August

Request Number: A-2023-001300

Request Summary: Correspondence relating to any abbreviated new drug submission (ANDS) filed since January 1, 2023 where the medicinal ingredient is estradiol alone and the product’s indications include the treatment of postmenopausal moderate to severe dyspareunia.

Disposition: Disclosed in part

Number of pages: 75

Date modified: